Shares of Alkermes plc (NASDAQ:ALKS – Get Free Report) gapped up before the market opened on Thursday after Deutsche Bank Aktiengesellschaft raised their price target on the stock from $40.00 to ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vicarious Surgical (RBOT – Research Report), Alkermes (ALKS ...
Analysts have set 12-month price targets for Alkermes, revealing an average target of $42.0, a high estimate of $52.00, and a ...
BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Thrivent Financial for Lutherans reduced its position in Alkermes plc (NASDAQ:ALKS – Free Report) by 3.3% in the fourth ...
In a report released today, Jason Gerberry from Bank of America Securities maintained a Hold rating on Alkermes (ALKS – Research Report), with ...
Investor's Business Daily on MSN11d
Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy PointsOn St. Patrick's Day, everybody's a little Irish. Alkermes, Aon, Jazz Pharmaceuticals, PDD Holdings and CRH are five ...
Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback